Literature DB >> 2948585

Identification and quantification of octanoyl glucuronide in the urine of children who ingested medium-chain triglycerides.

T Kuhara, I Matsumoto, M Ohno, T Ohura.   

Abstract

In addition to the previously described metabolites, octanoyl glucuronide was identified in the urine of four children who received medium-chain triglycerides. Octanoyl glucuronide in the urine of a child after ingestion of medium-chain triglycerides (C8:C10, 3:1) was quantitated as octanoic acid after glucuronidase treatment by means of gas chromatography/mass spectrometry. The urinary excretion increased rapidly to a maximum 1-2 h after ingestion, and decreased thereafter. During 0-3 h, 6.11 mumol of octanoyl glucuronide was excreted, which comprised 0.034% octanoic acid administered as glyceride, and 0.07% octanoic acid was postulated to be excreted as glucuronide within 24 h. Neither decanoyl glucuronide nor hexanoyl glucuronide was detected. Glucuronidation of branched medium-chain fatty acids, whose beta-oxidation is hindered, has been described previously. The present findings show that even straight-chain fatty acids undergo glucuronidation, although to a lesser extent, in addition to omega-oxidation and beta-oxidation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948585     DOI: 10.1002/bms.1200131103

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  3 in total

1.  Group tests for selective screening of inborn errors of metabolism.

Authors:  M Duran; L Dorland; S K Wadman; R Berger
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

2.  Metabolic fate of 2,2-dimethylbutyryl moiety of simvastatin in rats: identification of metabolites by gas chromatography/mass spectrometry.

Authors:  N Uchiyama; Y Kagami; Y Saito; S Abe; M Ohtawa; S Hata
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

3.  Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease.

Authors:  Mai Yamamoto; Meera Shanmuganathan; Lara Hart; Nikhil Pai; Philip Britz-McKibbin
Journal:  Metabolites       Date:  2021-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.